A First in California for Gene and Cell Therapy Research
Stanford opens a DEI door in a $12 million clinical trial backed by state
Chalking up a first in the world of stem cell and gene therapy research, especially in terms of openness and diversity, is not common. But Stanford University snagged one last week when it released a two-page document that previously had been under wraps.
The matter involves a $12 million award to Stanford researcher Rosa Bacchetta for a …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.